TCG Crossover Management, LLC - MOONLAKE IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

MOONLAKE IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 61559X104. A total of 24 filers reported holding MOONLAKE IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Links
Filings
Quarter-by-quarter ownership
TCG Crossover Management, LLC ownership history of MOONLAKE IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q4 2022$10,500,000
+35.3%
1,000,0000.0%1.85%
-20.4%
Q3 2022$7,760,000
+47.8%
1,000,0000.0%2.33%
+4.4%
Q2 2022$5,250,000–1,000,000–2.23%–
 Download
Other shareholders

There were no reported owners of MOONLAKE IMMUNOTHERAPEUTICS in Q2 2022.

NameSharesValueWeighting ↓
View complete list of MOONLAKE IMMUNOTHERAPEUTICS shareholders